Protocol Design Featured Articles

  1. BeiGene Explains The Landscape Of Oncology Trials In Brazil 12/16/2024

    In part one of this two-part series, BeiGene's Brazil and LATAM clinical operations head Lígia Campos details Brazil's cancer treatment landscape and the benefits of expanding oncology trials there.

  2. I AM INCLUDED: 8 Best Practices For Sites To Drive More Inclusive Clinical Trials 12/13/2024

    Discover the I AM INCLUDED framework, along with the actionable practices it provides to help all types of clinical trial sites extend the reach of their research.

  3. What's Needed To Transform Clinical Trials In Early-Stage Prostate Cancer 12/9/2024

    President and CEO of Candel Therapeutics Paul Peter Tak, MD, Ph.D., FMedSci calls for changes in early-stage prostate cancer clinical trials, from biomarkers to endpoints to technology.

  4. How Did Clinical Researchers Actually Use AI In 2024? 12/5/2024

    Looking ahead to 2025, Clinical Leader seeks to understand how clinical research professionals are incorporating AI into their work. So we asked them, “Simply put: Are you using any iteration of AI in your role within clinical research? If so, how and why?”

  5. Top 4 Trends For Neuropsychiatric Disease Research In 2025 12/3/2024

    Arrivo BioVentures' Kelly Abernathy and Joel Raskin, MD identify what they think will be the top four trends in neuropsychiatric disease research in the new year.

  6. 2024: Familiar Problems & Encouraging Progress 11/27/2024

    For part 1 of my 2024 recap, I asked various industry experts what stood out to them this year regarding the clinical trials industry. They mentioned significant challenges related to site capacity, enrollment, workforce changes, and trial complexity, but they also seemed encouraged with some of the efforts and emerging solutions that will address these issues.

  7. PI Insights From A Heart Failure Trial: Part 2 11/19/2024

    This is part 2 of Dan Schell’s interview with Jennifer Cowger, MD, the co-principal investigator of the Abbott TEAM-HF clinical trial. Here, she elaborates more on some of her tasks specific to this heart failure trial. 

  8. UCB Emphasizes Importance Of Patient-Centric Protocols 11/19/2024

    UCB Global Medical Head of Immunology John Ioannou emphasizes the need to partner with the healthcare community, supporting medical and patient organizations, but most importantly, patients to advance the design and execution of patient-centric clinical trials.

  9. PI Insights From A Heart Failure Trial: Part 1 11/14/2024

    Jennifer Cowger, MD, the co-principal investigator of the Abbott TEAM-HF clinical trial, talks about her role as a PI including trial design and meetings with the FDA.

  10. Scaling Gene Therapy Clinical Trials Through The Lens Of Ophthalmology 11/14/2024

    Ocugen CMO Huma Qamar, MD, MPH, CMI discusses scaling gene therapy clinical trials with special attention paid to logistical planning, collaboration with specialized centers, and managing future manufacturing needs.